ZA200203444B - Substituted indole mannich bases. - Google Patents

Substituted indole mannich bases.

Info

Publication number: ZA200203444B
Authority: ZA; South Africa
Prior art keywords: substituted indole; mannich bases; indole mannich; bases; substituted
Prior art date: 1999-12-27

Application number

ZA200203444A

Other languages

English (en)

Inventor

Matthias Gerlach

Corrina Maul

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-27

Filing date

2002-04-30

Publication date

2003-06-25

2002-04-30 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2003-06-25 Publication of ZA200203444B publication Critical patent/ZA200203444B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Addiction (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA200203444A 1999-12-27 2002-04-30 Substituted indole mannich bases. ZA200203444B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19963178A DE19963178A1 (de)	1999-12-27	1999-12-27	Substituierte Indol-Mannichbasen

Publications (1)

Publication Number	Publication Date
ZA200203444B true ZA200203444B (en)	2003-06-25

Family

ID=7934622

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200203444A ZA200203444B (en)	1999-12-27	2002-04-30	Substituted indole mannich bases.

Country Status (29)

Country	Link
US (1)	US7091220B2 (es)
EP (1)	EP1261585B1 (es)
JP (1)	JP2003519124A (es)
KR (1)	KR20020062314A (es)
CN (1)	CN1219763C (es)
AR (2)	AR027059A1 (es)
AT (1)	ATE374184T1 (es)
AU (1)	AU782585B2 (es)
BR (1)	BR0016747A (es)
CA (1)	CA2392866A1 (es)
CO (1)	CO5251383A1 (es)
CY (1)	CY1107080T1 (es)
CZ (1)	CZ20021708A3 (es)
DE (2)	DE19963178A1 (es)
DK (1)	DK1261585T3 (es)
ES (1)	ES2293935T3 (es)
HK (1)	HK1051367A1 (es)
HU (1)	HUP0203873A3 (es)
IL (1)	IL149426A0 (es)
NO (1)	NO20022803L (es)
NZ (1)	NZ518876A (es)
PE (1)	PE20010993A1 (es)
PL (1)	PL355446A1 (es)
PT (1)	PT1261585E (es)
RU (1)	RU2265594C2 (es)
SK (1)	SK8522002A3 (es)
UY (1)	UY26511A1 (es)
WO (1)	WO2001047885A1 (es)
ZA (1)	ZA200203444B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003000253A1 (en)	2001-06-20	2003-01-03	Wyeth	Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
TWI224101B (en) *	2001-06-20	2004-11-21	Wyeth Corp	Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
US7005445B2 (en)	2001-10-22	2006-02-28	The Research Foundation Of State University Of New York	Protein kinase and phosphatase inhibitors and methods for designing them
DE10153346A1 (de) *	2001-10-29	2004-04-22	Grünenthal GmbH	Substituierte Indole
UA80453C2 (en) *	2002-12-10	2007-09-25		Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
WO2004052855A2 (en) *	2002-12-10	2004-06-24	Wyeth	Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
DE60327550D1 (de) *	2002-12-10	2009-06-18	Wyeth Corp	Substituierte indoloxoacetylaminoessigsäurederivate als inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
CA2509170A1 (en) *	2002-12-10	2004-06-24	Wyeth	Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
ES2314289T3 (es) *	2002-12-10	2009-03-16	Wyeth	Derivados del acido 1h-indol-3-il glioxilico sustituidos con arilo, ariloxi y alquloxi como inhibidores del inhibidor del activador del plasminogeno-1(pai-1).
US7582773B2 (en) *	2003-09-25	2009-09-01	Wyeth	Substituted phenyl indoles
US7442805B2 (en)	2003-09-25	2008-10-28	Wyeth	Substituted sulfonamide-indoles
US7411083B2 (en)	2003-09-25	2008-08-12	Wyeth	Substituted acetic acid derivatives
US7351726B2 (en) *	2003-09-25	2008-04-01	Wyeth	Substituted oxadiazolidinediones
US7268159B2 (en)	2003-09-25	2007-09-11	Wyeth	Substituted indoles
US7332521B2 (en)	2003-09-25	2008-02-19	Wyeth	Substituted indoles
US7163954B2 (en) *	2003-09-25	2007-01-16	Wyeth	Substituted naphthyl benzothiophene acids
US7420083B2 (en)	2003-09-25	2008-09-02	Wyeth	Substituted aryloximes
US7141592B2 (en) *	2003-09-25	2006-11-28	Wyeth	Substituted oxadiazolidinediones
US7342039B2 (en) *	2003-09-25	2008-03-11	Wyeth	Substituted indole oximes
US7265148B2 (en)	2003-09-25	2007-09-04	Wyeth	Substituted pyrrole-indoles
US7534894B2 (en) *	2003-09-25	2009-05-19	Wyeth	Biphenyloxy-acids
US7446201B2 (en) *	2003-09-25	2008-11-04	Wyeth	Substituted heteroaryl benzofuran acids
BRPI0514544A (pt) *	2004-08-23	2008-06-17	Wyeth Corp	ácidos de oxazol-naftila como moduladores de inibidor tipo-1 de ativador de plasminogênio (pai-1)
EP1794138A2 (en)	2004-08-23	2007-06-13	Wyeth	Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
MX2007002177A (es) *	2004-08-23	2007-04-02	Wyeth Corp	Acidos de pirrolo-naftilo como inhibidores de pai-1.
MX2008002117A (es) *	2005-08-17	2008-09-26	Wyeth Corp	Indoles sustituidos y metodos de uso de estos.
US7838542B2 (en)	2006-06-29	2010-11-23	Kinex Pharmaceuticals, Llc	Bicyclic compositions and methods for modulating a kinase cascade
DE102006033109A1 (de) *	2006-07-18	2008-01-31	Grünenthal GmbH	Substituierte Heteroaryl-Derivate
EP2424918A4 (en) *	2009-05-01	2013-03-27	Henkel Corp	HARDENING ACCELERATOR FOR ANAEROBIC HARDENABLE COMPOSITIONS
WO2013032960A2 (en) *	2011-08-26	2013-03-07	Uwm Research Foundation, Inc.	Vitamin d receptor - coregulator inhibitors
CN102687719A (zh) *	2012-06-04	2012-09-26	陕西海安实业有限责任公司	一种新型高效油田用杀菌剂及其制备方法
US20170174825A1 (en) *	2014-03-18	2017-06-22	The Board Of Regents For Oklahoma State University	Systems and methods for production of artificial eumelanin
KR102729280B1 (ko) *	2016-10-28	2024-11-12	서울대학교병원	3-아미노알킬레이티드 인돌 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3296072A (en) *	1962-06-11	1967-01-03	Upjohn Co	Method of treating mental depression
FR2181559A1 (en) *	1972-04-28	1973-12-07	Aec Chimie Organique Bio	N-Phenylalkyl-N-3-indolylalkyl-alkylamines - with sedative, neuroleptic, analgesic, hypotensive, antiserotonin, adrenolytic activity
GB1374414A (en) *	1972-06-12	1974-11-20	Sterling Drug Inc	1-acyl-3-amino-alkyl-indoles and their preparation
GB1456208A (en) *	1972-12-28	1976-11-24	Agfa Gevaert	Thermographic processes and recording material for use therein
DE2724809A1 (de)	1977-06-02	1978-08-31	Dieter P Philippen	Urinflaschen-spuelgeraet
US4341402A (en) *	1980-03-06	1982-07-27	Sterling Drug Inc.	Systems employing indole color formers
DE3209305A1 (de)	1982-03-15	1983-09-22	SIC AG, 4020 Basel	Verfahren zur automatischen entleerung und reinigung von hygienegefaessen unter optimaler zufuehrung des spuelwassers bei minimalem wasserverbrauch
FR2574077A1 (fr) *	1984-12-04	1986-06-06	Glaxo Group Ltd	Derives d'indoles, leur preparation et les compositions pharmaceutiques les contenant
SE449483B (sv)	1986-03-12	1987-05-04	Juhani Jervinen	Anordning for att avlegsna urin fran en flexibel urinuppsamlingspase
US4855448A (en) *	1986-08-26	1989-08-08	A. H. Robins Company, Incorporated	2-Amino-3-aroyl-γ-oxobenzenebutanoic acids and esters
GB9226532D0 (en)	1992-12-21	1993-02-17	Smithkline Beecham Plc	Compounds
GB9226537D0 (en) *	1992-12-21	1993-02-17	Smithkline Beecham Plc	Compounds
CA2130294A1 (en)	1994-08-17	1996-02-18	F. W. Arthur Morrow	Method of cleaning an ostomy pouch
CA2234166A1 (en) *	1995-10-10	1997-04-17	Patric James Hahn	N-¬2-substituted-3-(2-aminoethyl)-1h-indol-5-yl\|-amides: new 5-ht1f agonists
US5735301A (en) *	1996-02-22	1998-04-07	Rower; Gary	Urostomy patient equipment irrigation system
GEP20032920B (en) *	1998-02-25	2003-03-25	Genetics Inst	Inhibitors of Phospholipase Enzymes
DE19823326A1 (de)	1998-05-26	1999-12-02	Volker Fesser	Einrichtung zum Entleeren und Desinfizieren von Urin- und Sekretbeuteln
DE19963177A1 (de) *	1999-12-27	2001-07-12	Gruenenthal Gmbh	Substanzbibliothek
US6263887B1 (en)	2000-01-14	2001-07-24	Dornoch Medical Systems, Inc.	Liquid waste disposal and canister flushing system and method

1999
- 1999-12-27 DE DE19963178A patent/DE19963178A1/de not_active Ceased
2000
- 2000-12-20 CN CNB008177317A patent/CN1219763C/zh not_active Expired - Fee Related
- 2000-12-20 IL IL14942600A patent/IL149426A0/xx unknown
- 2000-12-20 RU RU2002120478/04A patent/RU2265594C2/ru not_active IP Right Cessation
- 2000-12-20 JP JP2001549357A patent/JP2003519124A/ja not_active Withdrawn
- 2000-12-20 BR BR0016747-9A patent/BR0016747A/pt not_active IP Right Cessation
- 2000-12-20 WO PCT/EP2000/012974 patent/WO2001047885A1/de active Search and Examination
- 2000-12-20 CZ CZ20021708A patent/CZ20021708A3/cs unknown
- 2000-12-20 ES ES00991219T patent/ES2293935T3/es not_active Expired - Lifetime
- 2000-12-20 CA CA002392866A patent/CA2392866A1/en not_active Abandoned
- 2000-12-20 AT AT00991219T patent/ATE374184T1/de active
- 2000-12-20 KR KR1020027007032A patent/KR20020062314A/ko not_active Application Discontinuation
- 2000-12-20 US US10/168,985 patent/US7091220B2/en not_active Expired - Fee Related
- 2000-12-20 AU AU31610/01A patent/AU782585B2/en not_active Ceased
- 2000-12-20 HU HU0203873A patent/HUP0203873A3/hu unknown
- 2000-12-20 DK DK00991219T patent/DK1261585T3/da active
- 2000-12-20 PL PL00355446A patent/PL355446A1/xx not_active Application Discontinuation
- 2000-12-20 SK SK852-2002A patent/SK8522002A3/sk unknown
- 2000-12-20 NZ NZ518876A patent/NZ518876A/en unknown
- 2000-12-20 PT PT00991219T patent/PT1261585E/pt unknown
- 2000-12-20 EP EP00991219A patent/EP1261585B1/de not_active Expired - Lifetime
- 2000-12-20 DE DE50014679T patent/DE50014679D1/de not_active Expired - Lifetime
- 2000-12-21 AR ARP000106840A patent/AR027059A1/es not_active Application Discontinuation
- 2000-12-21 AR ARP000106841A patent/AR027060A1/es unknown
- 2000-12-22 CO CO00097385A patent/CO5251383A1/es not_active Application Discontinuation
- 2000-12-26 PE PE2000001397A patent/PE20010993A1/es not_active Application Discontinuation
- 2000-12-27 UY UY26511A patent/UY26511A1/es not_active Application Discontinuation
2002
- 2002-04-30 ZA ZA200203444A patent/ZA200203444B/xx unknown
- 2002-06-12 NO NO20022803A patent/NO20022803L/no not_active Application Discontinuation
2003
- 2003-05-22 HK HK03103625A patent/HK1051367A1/xx not_active IP Right Cessation
2007
- 2007-12-10 CY CY20071101569T patent/CY1107080T1/el unknown

Also Published As

Publication number	Publication date
PL355446A1 (en)	2004-04-19
CA2392866A1 (en)	2001-07-05
HUP0203873A3 (en)	2005-03-29
AU3161001A (en)	2001-07-09
WO2001047885A1 (de)	2001-07-05
EP1261585A1 (de)	2002-12-04
NZ518876A (en)	2005-02-25
DE19963178A1 (de)	2001-07-05
CY1107080T1 (el)	2012-10-24
RU2002120478A (ru)	2004-01-10
PT1261585E (pt)	2007-12-11
PE20010993A1 (es)	2001-10-06
US20030060497A1 (en)	2003-03-27
ATE374184T1 (de)	2007-10-15
NO20022803D0 (no)	2002-06-12
CN1413192A (zh)	2003-04-23
DK1261585T3 (da)	2007-12-17
ES2293935T3 (es)	2008-04-01
DE50014679D1 (de)	2007-11-08
AR027060A1 (es)	2003-03-12
AR027059A1 (es)	2003-03-12
US7091220B2 (en)	2006-08-15
RU2265594C2 (ru)	2005-12-10
CO5251383A1 (es)	2003-02-28
HUP0203873A2 (hu)	2003-03-28
KR20020062314A (ko)	2002-07-25
HK1051367A1 (en)	2003-08-01
CN1219763C (zh)	2005-09-21
IL149426A0 (en)	2002-11-10
NO20022803L (no)	2002-06-12
SK8522002A3 (en)	2002-12-03
CZ20021708A3 (cs)	2002-08-14
UY26511A1 (es)	2001-01-31
EP1261585B1 (de)	2007-09-26
BR0016747A (pt)	2002-09-03
JP2003519124A (ja)	2003-06-17
AU782585B2 (en)	2005-08-11

Publication	Publication Date	Title
ZA200203444B (en)	2003-06-25	Substituted indole mannich bases.
ZA200000894B (en)	2000-08-24	4-Phenyl-pyridine derivatives.
ZA200201055B (en)	2003-07-30	Amino-triazolopyridine derivatives.
MXPA02005101A (es)	2003-09-25	Derivados de indol canabimimeticos.
HK1051037A1 (en)	2003-07-18	Benzodiazepine derivatives.
HK1051038A1 (en)	2003-07-18	Benzodiazepine derivatives.
ZA988078B (en)	2000-03-22	Substituted oxindole derivatives.
ZA200203581B (en)	2004-02-25	Bicyclic imidazo-3-yl-amine derivatives.
ZA200109595B (en)	2003-05-28	13-methyl-erythromycin derivatives.
HK1046411A1 (en)	2003-01-10	5-Phenyl-pyrimidine derivatives.
HK1051863A1 (en)	2003-08-22	Indol-3-yl derivatives.
HK1044481A1 (zh)	2002-10-25	化合物
HK1037619A1 (en)	2002-02-15	Indole derivatives.
MXPA01012041A (es)	2003-09-04	Derivados de indol.
ZA200110053B (en)	2002-07-03	Factor via inhibitors.
ZA200108913B (en)	2003-03-26	Imidazodiazepine derivative.
HK1049161A1 (en)	2003-05-02	Indole derivatives.
IL150336A0 (en)	2002-12-01	Novel indole derivatives
MXPA00011504A (es)	2003-12-12	Derivados heterociclicos sustituidos.
ZA200201276B (en)	2003-07-30	3-Amino-2-phenyl-propane derivatives.
EP1226140A4 (en)	2003-03-12	NEW INDOLIC COMPOUNDS
PT1246799E (pt)	2004-03-31	Bases de mannich de pirrol substituidas
HK1054382A1 (en)	2003-11-28	Substituted pyrroles.
MXPA01011285A (es)	2003-09-04	Derivados de tio-oxindol.
EP1187608A4 (en)	2004-02-25	INDOLE-BASED COMPOUNDS